MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tremors: Treatment"

  • 2019 International Congress

    Deep brain stimulation of Caudal Zona incerta: Case series

    DR. Ginjupally, Z. Guduru, T. Hines Iii, T. Ali, G. Quintero, C. van Horne (Lexington, KY, USA)

    Objective: With the advancement of deep brain stimulation (DBS) techniques, a renewed interest in the posterior sub thalamic area (PSA) for the treatment of Parkinson's…
  • 2019 International Congress

    VIM stimulation for refractory tremor -the Sheba experience

    V. Livneh, S. Korn, G. Yaalom, T. Karmon, H. Strauss, Z. Zibly, R. Spiegelmann, S. Baer (Tel Aviv, Israel)

    Objective: This study describes our center's experience with 26 patients who underwent surgery for thalamic ventral intermediate nucleus (VIM) stimulation between years 2008-2018 Background: Deep-brain…
  • 2019 International Congress

    Compression Therapy: A Treatment of Rubral Tremor

    D. Nacopoulos (Erie, PA, USA)

    Objective: To present a case of a post-stroke rubral tremor which benefited from compression therapy to the affected arm, improving medication-refractory tremor. Background: Rubral and ataxic…
  • 2019 International Congress

    GABA-A Receptor Positive Allosteric Modulators: Phase 2 Proof of Concept Studies of Brexanolone Injection and SAGE-217 in Essential Tremor

    J. Paskavitz, A. Bullock, D. Nguyen, A. Smith, B. Farley, M. Quirk, I. Kaul, S. Li, A. Ellenbogen, C. Silber, J. Doherty, H. Colquhoun, S. Kanes (Cambridge, MA, USA)

    Objective: To examine use of γ-aminobutyric acid (GABA) type A receptor (GABA-A-R) positive allosteric modulators (PAMs) in the treatment of essential tremor (ET) in early…
  • 2019 International Congress

    Successful Treatment of Orthostatic Tremor using Perampanel

    A. Wadhwa, S. Schaefer (New Haven, CT, USA)

    Objective: Orthostatic tremor is notoriously difficult to treat. To date, there has only been one case report of marked improvement of symptoms using perampanel. We present…
  • 2019 International Congress

    DBS Programming In Tremor And Akinetic-Rigid Predominant Parkinson’s Disease

    Z. Guduru, D. Ginjupally, T. Ali, N. El Seblani, J. Quintero, C. van Horne (Lexington, KY, USA)

    Objective: Deep brain stimulation (DBS) targeting Globus pallidus pars interna (GPi) and subthalamic nucleus (STN) is an established surgical treatment for Parkinson’s disease (PD). Due…
  • 2019 International Congress

    The STN Sweet Spot for Tremor Control in Parkinson’s Disease

    T. Stiep, A. Diaz, I. Cajigas, J. Jagid, C. Luca (Miami, FL, USA)

    Objective: Describe 4 cases of Parkinson’s disease (PD) patients with residual tremor post deep brain stimulation of subthalamic nucleus (DBS-STN) that underwent repositioning of electrodes…
  • 2019 International Congress

    Is directional stimulation of the VIM superior to omnidirectional stimulation in patients with essential tremor?

    S. Fliegen, P. Nikolov, C. Hartmann, P. Slotty, J. Vesper, A. Schnitzler, S. Groiß (Düsseldorf, Germany)

    Objective: To determine whether directional stimulation of the VIM is superior to omnidirectional stimulation in essential tremor. Background: Deep brain stimulation (DBS) of the VIM…
  • 2019 International Congress

    Resting-State fMRI in Essential Tremor after MRgFUS treatment

    C. Kindler, V. Purrer, N. Upadhyay, V. Keil, V. Borger, C. Pieper, L. Scheef, H. Boecker, U. Wuellner (Bonn, Germany)

    Objective: Identify network alterations in essential tremor (ET) after magnetic resonance–guided focused ultrasound (MRgFUS) treatment using independent component analysis (ICA). Background: MRgFUS has been approved…
  • 2018 International Congress

    The complementary relationship between zonisamide and istradefylline in treating patients with Parkinson’s disease

    T. Kadowaki, M. Hamaguchi, H. Sakuramoto, T. Shiina, H. Fujita, K. Suzuki, K. Hirata (Mibu, Japan)

    Objective: To investigate patients with Parkinson’s disease (PD) who received zonisamide and istradefylline at the same period. Background: Zonisamide and istradefylline are anti-PD drugs with…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 18
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley